Amyloid β protein 1-42/43 (Aβ 1-42/43) in cerebellar diffuse plaques

enzyme-linked immunosorbent assay and immunocytochemical study

Akira Tamaoka, Naoya Sawamura, Asano Odaka, Nobuhiro Suzuki, Hidehiro Mizusawa, Shin'ichi Shoji, Hiroshi Mori

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Diffuse plaques are immature and amorphous senile plaques and believed to be in the initial phase of plaque formation. In contrast to amyloid angiopathy and the plaque core amyloid, diffuse plaques failed to be purified in preserved forms from the brain. Here, we studied the diffuse plaques in the cerebellar region of the Alzheimer's disease brain based on immunocytochemistry and ELISA using two different monoclonal antibodies specifically recognizing the car{ballot box}yl termini of Aβ molecules (BA27 for Aβ 1-40 and BC05 for Aβ 1-42/43). We found that the amount of Aβ 1-40 was in proportion to the staining degree on amyloid angiopathy by immunohistochemistry. We found that Aβ 1-42/43 comprised diffuse plaques as the major component in the cerebella of AD brains. Taking these findings into consideration, diffuse plaques, the earliest pathological change in the brain with AD, are concluded to be composed mainly of Aβ 1-42/43, implicating the critical importance of this kind of Aβ species deposition in the pathogenesis of AD.

Original languageEnglish
Pages (from-to)151-156
Number of pages6
JournalBrain Research
Volume679
Issue number1
DOIs
Publication statusPublished - 1995 May 8
Externally publishedYes

Fingerprint

Amyloidogenic Proteins
Amyloid Plaques
Enzyme-Linked Immunosorbent Assay
Brain
Immunohistochemistry
Cerebellum
Alzheimer Disease
Monoclonal Antibodies
Staining and Labeling
Amyloid angiopathy

Keywords

  • Alzheimer's disease
  • Amyloid angiopathy
  • Amyloid β protein
  • Cerebellum
  • Diffuse plaque
  • Enzyme-linked immunosorbent assay
  • Immunocytochemistry

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Amyloid β protein 1-42/43 (Aβ 1-42/43) in cerebellar diffuse plaques : enzyme-linked immunosorbent assay and immunocytochemical study. / Tamaoka, Akira; Sawamura, Naoya; Odaka, Asano; Suzuki, Nobuhiro; Mizusawa, Hidehiro; Shoji, Shin'ichi; Mori, Hiroshi.

In: Brain Research, Vol. 679, No. 1, 08.05.1995, p. 151-156.

Research output: Contribution to journalArticle

Tamaoka, Akira ; Sawamura, Naoya ; Odaka, Asano ; Suzuki, Nobuhiro ; Mizusawa, Hidehiro ; Shoji, Shin'ichi ; Mori, Hiroshi. / Amyloid β protein 1-42/43 (Aβ 1-42/43) in cerebellar diffuse plaques : enzyme-linked immunosorbent assay and immunocytochemical study. In: Brain Research. 1995 ; Vol. 679, No. 1. pp. 151-156.
@article{abee2bf84cbc40daa6615e6f81cffec2,
title = "Amyloid β protein 1-42/43 (Aβ 1-42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study",
abstract = "Diffuse plaques are immature and amorphous senile plaques and believed to be in the initial phase of plaque formation. In contrast to amyloid angiopathy and the plaque core amyloid, diffuse plaques failed to be purified in preserved forms from the brain. Here, we studied the diffuse plaques in the cerebellar region of the Alzheimer's disease brain based on immunocytochemistry and ELISA using two different monoclonal antibodies specifically recognizing the car{ballot box}yl termini of Aβ molecules (BA27 for Aβ 1-40 and BC05 for Aβ 1-42/43). We found that the amount of Aβ 1-40 was in proportion to the staining degree on amyloid angiopathy by immunohistochemistry. We found that Aβ 1-42/43 comprised diffuse plaques as the major component in the cerebella of AD brains. Taking these findings into consideration, diffuse plaques, the earliest pathological change in the brain with AD, are concluded to be composed mainly of Aβ 1-42/43, implicating the critical importance of this kind of Aβ species deposition in the pathogenesis of AD.",
keywords = "Alzheimer's disease, Amyloid angiopathy, Amyloid β protein, Cerebellum, Diffuse plaque, Enzyme-linked immunosorbent assay, Immunocytochemistry",
author = "Akira Tamaoka and Naoya Sawamura and Asano Odaka and Nobuhiro Suzuki and Hidehiro Mizusawa and Shin'ichi Shoji and Hiroshi Mori",
year = "1995",
month = "5",
day = "8",
doi = "10.1016/0006-8993(95)00162-J",
language = "English",
volume = "679",
pages = "151--156",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Amyloid β protein 1-42/43 (Aβ 1-42/43) in cerebellar diffuse plaques

T2 - enzyme-linked immunosorbent assay and immunocytochemical study

AU - Tamaoka, Akira

AU - Sawamura, Naoya

AU - Odaka, Asano

AU - Suzuki, Nobuhiro

AU - Mizusawa, Hidehiro

AU - Shoji, Shin'ichi

AU - Mori, Hiroshi

PY - 1995/5/8

Y1 - 1995/5/8

N2 - Diffuse plaques are immature and amorphous senile plaques and believed to be in the initial phase of plaque formation. In contrast to amyloid angiopathy and the plaque core amyloid, diffuse plaques failed to be purified in preserved forms from the brain. Here, we studied the diffuse plaques in the cerebellar region of the Alzheimer's disease brain based on immunocytochemistry and ELISA using two different monoclonal antibodies specifically recognizing the car{ballot box}yl termini of Aβ molecules (BA27 for Aβ 1-40 and BC05 for Aβ 1-42/43). We found that the amount of Aβ 1-40 was in proportion to the staining degree on amyloid angiopathy by immunohistochemistry. We found that Aβ 1-42/43 comprised diffuse plaques as the major component in the cerebella of AD brains. Taking these findings into consideration, diffuse plaques, the earliest pathological change in the brain with AD, are concluded to be composed mainly of Aβ 1-42/43, implicating the critical importance of this kind of Aβ species deposition in the pathogenesis of AD.

AB - Diffuse plaques are immature and amorphous senile plaques and believed to be in the initial phase of plaque formation. In contrast to amyloid angiopathy and the plaque core amyloid, diffuse plaques failed to be purified in preserved forms from the brain. Here, we studied the diffuse plaques in the cerebellar region of the Alzheimer's disease brain based on immunocytochemistry and ELISA using two different monoclonal antibodies specifically recognizing the car{ballot box}yl termini of Aβ molecules (BA27 for Aβ 1-40 and BC05 for Aβ 1-42/43). We found that the amount of Aβ 1-40 was in proportion to the staining degree on amyloid angiopathy by immunohistochemistry. We found that Aβ 1-42/43 comprised diffuse plaques as the major component in the cerebella of AD brains. Taking these findings into consideration, diffuse plaques, the earliest pathological change in the brain with AD, are concluded to be composed mainly of Aβ 1-42/43, implicating the critical importance of this kind of Aβ species deposition in the pathogenesis of AD.

KW - Alzheimer's disease

KW - Amyloid angiopathy

KW - Amyloid β protein

KW - Cerebellum

KW - Diffuse plaque

KW - Enzyme-linked immunosorbent assay

KW - Immunocytochemistry

UR - http://www.scopus.com/inward/record.url?scp=0028922520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028922520&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(95)00162-J

DO - 10.1016/0006-8993(95)00162-J

M3 - Article

VL - 679

SP - 151

EP - 156

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -